Treating 3 million people living with HIV/AIDS by 2005

January 2004
WHO Drug Information;2004, Vol. 18 Issue 1, p11
Academic Journal
Presents news briefs related to global HIV/AIDS treatment as of 2004. World Health Organization's launching of a strategy for treating three million people with HIV/AIDS by 2005; Mechanism for expanding access to quality and effective treatment for HIV/AIDS under the AIDS medicines and diagnostic service; Generic products added to the World Health Organization's Prequalification Project for first-line HIV treatment.


Related Articles

  • INTENSIFIED TUBERCULOSIS CASE FINDING AMONG HIV-INFECTED INDIVIDUALS. Kranzer, K. // CME: Continuing Medical Education;Oct2011, Vol. 29 Issue 10, p418 

    The article shows the developments on the HIV-tuberculosis (TB) co-epidemic in South Africa. A report showed that about 60 percent of TB patients the country were infected by HIV, where the mix of those diseases contributed to deaths of 380,000 TB patients. The World Health Organization and the...

  • "I will not let my HIV status stand in the way." Decisions on motherhood among women on ART in a slum in Kenya- a qualitative study. Ujiji, Opondo Awiti; Ekström, Anna Mia; Ilako, Festus; Indalo, Dorcas; Rubenson, Birgitta // BMC Women's Health;2010, Vol. 10, p13 

    Background: The African Medical Research Foundation antiretroviral therapy program at the community health centre in Kibera counsels women to wait with pregnancy until they reach the acceptable level of 350 cells/ml CD4 count and to discuss their pregnancy intentions with their health care...

  • Buprenorphine Use: The International Experience. Carrieri, Maria Patrizia; Amass, Leslie; Lucas, Gregory M.; Vlahov, David; Wodak, Alex; Woody, George E. // Clinical Infectious Diseases;12/15/2006 Supplement, Vol. 43, pS197 

    The confluence of the heroin injection epidemic and the human immunodeficiency virus (HIV) infection epidemic has increased the call for expanded access to effective treatments for both conditions. Buprenorphine and methadone are now listed on the World Health Organization's Model Essential...

  • Strengthening adherence to Anti Retroviral Therapy (ART) monitoring and support: operation research to identify barriers and facilitators in Nepal. Bam, Kiran; Rajbhandari, Rajesh M.; Karmacharya, Dibesh B.; Dixit, Sameer M. // BMC Health Services Research;2015, Vol. 15 Issue 1, p1 

    Background: Anti Retroviral Therapy (ART) is the cornerstone for comprehensive health sector response to Human Immunodeficiency Virus (HIV) treatment, care and support. Adherence of at least 95% is needed to keep HIV under control, as per World Health Organization (WHO) guidelines. This study...

  • WHY SHOULD WE STILL CARE ABOUT THE STAVUDINE DOSE? Innes, Steve; Cotton, Mark; Venter, François // Southern African Journal of HIV Medicine;Dec2011, Vol. 12 Issue 4, p14 

    Current recommendations advise that stavudine be phased out of use. The logistics and cost of switching are significant, and the World Health Organization has forecast that 1.55 million people will still be on stavudinebased antiretroviral therapy by the end of 2012. Stavudine is co-formulated...

  • Ambitious plans to roll out ARVs.  // HIV Australia;Mar-May2004, Vol. 3 Issue 3, p5 

    Reports on the plan to launch antiviral treatment programs at several pilot centres for HIV-positive people across Zimbabwe in 2004. Support of the World Health Organization for the program; Cost of a triple generic drug treatment; Reasons for choosing the pilot sites for the program.

  • HIV treatment access: accomplishments and aspirations.  // PharmacoEconomics & Outcomes News;8/26/2006, Issue 510, p2 

    The article reports on the worldwide efforts of the World Health Organization (WHO) in the prevention and treatment of HIV infections, tuberculosis (TB) and HIV coinfection. WHO HIV/AIDS director Kevin De Cock announced a substantial increase in the access to antiretroviral therapy in...

  • WHEN TO START ANTIRETROVIRAL THERAPY IN ADULTS: THE RESULTS OF HPTN 052 MOVE US CLOSER TO A 'TEST-AND-TREAT' POLICY. Geffen, Nathan // Southern African Journal of HIV Medicine;Sep2011, Vol. 12 Issue 3, p9 

    When is the best time to initiate antiretroviral therapy (ART) in adults? This is a vital question in HIV treatment and prevention services. More specifically, is the 350 cells/μl CD4 count threshold recommended by current World Health Organization (WHO) guidelines sufficient, or should we...

  • HIV treatment will boost pre- vention and strengthen health systems,says The world health report 2004.  // Bulletin of the World Health Organization;Jun2004, Vol. 82 Issue 6, p477 

    The article presents information on the World Health Report 2004 , launched by World Health Organization in Geneva on May 11, 2004. The report reveals that by using human immunodeficiency virus treatment programs to holster existing prevention efforts and improve overall health systems in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics